about
Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumorsEvaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors.Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanomaNestin depletion induces melanoma matrix metalloproteinases and invasionLeukotriene B4-driven neutrophil recruitment to the skin is essential for allergic skin inflammation.Melanoma biomarkers: current status and vision for the future.Systemic lupus erythematosus-associated neutrophilic dermatosis: a review and update.Utility of immunofluorescence testing for vascular IgA in adult patients with leukocytoclastic vasculitis.Hypersensitivity reaction as a harbinger of acute myeloid leukemia: a case report and review of the literature.Merkel cell carcinoma expresses vasculogenic mimicry: demonstration in patients and experimental manipulation in xenografts.Post-transplant diagnosis of hereditary leiomyomatosis and renal cell carcinoma syndrome in a kidney donor.Uncovering bias in the cytologic evaluation of cervical squamous lesions.Airway recovery after face transplantation.Calciphylaxis and the persistence of medical misinformation in the era of Google.A prostaglandin D-synthase-positive mast cell gradient characterizes scalp patterning.Systemic lupus erythematosus-associated neutrophilic dermatosis--an underrecognized neutrophilic dermatosis in patients with systemic lupus erythematosus.The clinician-educator has no clothes.Impact of the 2009 AJCC staging guidelines for melanoma on the number of mitotic figures reported by dermatopathologists at one institution.Duration of symptoms does not correlate with results of T-cell gene rearrangement studies in patients evaluated for cutaneous T-cell lymphoma.Tibial nerve decompression in patients with tarsal tunnel syndrome: pressures in the tarsal, medial plantar, and lateral plantar tunnelsImpact of financially driven health care models on tenets of medical professionalism including workforce equity, diversity, and inclusion
P50
Q33831398-D90ACF44-CFFE-4FF7-BB16-6AFD0DC1B5CEQ33935045-CF9401FA-4455-4C6C-B2A1-D8A9257F2E1BQ34299814-3B655BBA-6BA8-4812-9F5C-A150E24BF526Q35569170-D7EAC8A3-C5CD-4948-B339-CB601ADACA3BQ36338996-872A66BA-3282-4634-B73D-11D29E96907CQ37357928-5EF44DCB-EBF0-44DF-BA02-579D185FF836Q38218735-FB56170D-9C03-4835-B89C-5F83C0715DC3Q38240118-F763BE6C-966C-4785-9F92-A42E85CA238AQ38401165-FC9897D0-7B97-40E3-9A24-85BF38DCB491Q38967137-B5E2ACD3-DEF1-4817-B7B7-52C9CA452475Q39368963-94477320-8FA5-412B-BFEE-B891CEE4A7A5Q41597656-AB3342BB-D448-4690-9358-5F601A49850DQ41653424-D30AFFCE-C959-4D06-8151-B187BAC07DAFQ43842769-9859DC5A-88F6-4DE7-8803-0CA80C4DBFEFQ46537015-2DA1D866-85E5-4A1E-BAE8-161A425D3A89Q46933778-79CD0DA9-6315-48D7-B062-C7633838DC2CQ48224960-BCD9238D-FA15-48FB-9ABB-62A5A59D6207Q52946964-AE7AAD48-323E-417C-9314-E61CE82AA0B0Q53522649-8377CB8A-200D-4E9C-A876-A74EF3A7E5BDQ84946304-AED3C75B-BF50-4555-BD01-8A30C384EA36Q90043780-AD254FDF-EB93-420E-8665-BD5419FC9CF5
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Allison R Larson
@ast
Allison R Larson
@en
Allison R Larson
@es
type
label
Allison R Larson
@ast
Allison R Larson
@en
Allison R Larson
@es
prefLabel
Allison R Larson
@ast
Allison R Larson
@en
Allison R Larson
@es
P1053
N-4263-2015
P106
P31
P3829
P496
0000-0001-8534-7078